RXL:ARCA-ProShares Ultra Health Care

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing Price

USD 96.86

Change

+0.76 (+0.80)%

Market Cap

USD 0.12B

Volume

7.48K

Yahoo Analyst Target

N/A

STA Analyst Target

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Health Care TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.06%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
FAS Direxion Financial Bull 3X Sha.. 0.00 %

-0.45 (-0.60%)

USD 2.84B
SSO ProShares Ultra S&P500 0.90 %

-0.82 (-0.69%)

USD 2.55B
QLD ProShares Ultra QQQ 0.95 %

-0.46 (-0.56%)

USD 1.66B
TNA Direxion Small Cap Bull 3X Sha.. 0.95 %

-2.94 (-3.76%)

USD 1.64B
UPRO ProShares UltraPro S&P 500 0.95 %

-1.64 (-1.04%)

USD 1.46B
SPXL Direxion Daily S&P 500 Bull 3X.. 0.95 %

-0.53 (-1.06%)

USD 1.06B
UYG ProShares Ultra Financials 0.95 %

-0.70 (-0.52%)

USD 1.01B
NUGT Direxion Daily Gold Miners Ind.. 0.90 %

+1.52 (+4.39%)

USD 0.80B
SOXL Direxion Daily Semiconductor B.. 0.95 %

+1.72 (+1.07%)

USD 0.72B
UDOW ProShares UltraPro Dow30 0.95 %

-0.19 (-0.18%)

USD 0.61B

ETFs Containing RXL

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Trading--Leveraged Equity)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.77% 55% F 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.77% 55% F 92% A-
Trailing 12 Months  
Capital Gain 51.58% 59% F 93% A
Dividend Return 0.16% 9% F 2% F
Total Return 51.74% 58% F 93% A
Trailing 5 Years  
Capital Gain 322.85% 72% C- 97% A+
Dividend Return 4.35% 53% F 10% F
Total Return 327.20% 74% C 97% A+
Average Annual (5 Year Horizon)  
Capital Gain 28.57% 79% C+ 95% A
Dividend Return 28.94% 79% C+ 95% A
Total Return 0.37% 49% F 7% F
Risk Return Profile  
Volatility (Standard Deviation) 29.24% 60% D- 20% F
Risk Adjusted Return 98.98% 79% C+ 79% C+
Market Capitalization 0.07B 66% D 22% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.